Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer. Abril YLN, Fernandez IR, Hong JY, Chiang YL, et al. Oncogene 2021 Jan 21. pii: 10.1038/s41388-020-01637.

Read + Share

Amedeo Smart

Independent Medical Education

Abril YLN, Fernandez IR, Hong JY, Chiang YL, et al. Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer. Oncogene 2021 Jan 21. pii: 10.1038/s41388-020-01637.
PMID: 33479498